Searched for
THE EUROPEAN JOURNAL OF IMMUNOLOGY
BA.5 sub-variant can re-infect you with Covid 'within weeks': ExpertsThat means even if you were infected in 2020 with Delta or even Omicron BA.1 last winter, you can still get BA.5. Your previous immunity do...
UK, US scientists call for fuller probe into COVID-19 Wuhan lab leak theoryA group of leading UK and US scientists, including Indian-origin Cambridge University immunology and infectious disease expert Ravindra Gup...
Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccineThe half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data.
After a year-long sprint, coronavirus vaccines are finally at hand, but questions remainThe European Medicines Agency (EMA), charged with overseeing drug approval in the European Union, told AFP that it could approve the first ...
UK asks regulator to assess AstraZeneca-Oxford vaccine amid questionsU.K. Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency to determine whether the vacci...
Questions over AstraZeneca's COVID-19 vaccine data risk delaying approvalSeveral scientists have raised doubts about the robustness of results showing the shot was 90% effective in a sub-group of trial participan...
Sputnik V vaccine 92% effective on COVID-19: Russia institute"We are responsible for monitoring the effectiveness of the Sputnik V vaccine among citizens who have received it as part of the mass vacci...
Antibodies detectable up to 7 months after Covid infection, number depends on severity of diseaseThe study revealed that 90 per cent of subjects have detectable antibodies.
Antibodies against coronavirus detectable up to seven months post COVID-19 onset, says studyThe study revealed that 90 per cent of subjects have detectable antibodies up to seven months post contracting COVID-19. It also found that...
Mutations undergone by coronavirus tracked, three lineages discovered: StudyAccording to the researchers, including those from the University of Cambridge in the UK, there are three distinct "variants" of COVID-19, ...
Age is not the only risk for severe coronavirus diseaseThe majority of people who get COVID-19 have mild or moderate symptoms. But "majority" doesn't mean "all," and that raises an important que...
- 'Need to get more Europeans to pursue research in India'
Kolkata, Dec 20 (IANS) While a considerable number of Indians are already engaged in research at European facilities, there is a need to en...